ABT · 10-Q · 2026Q2 · Full report

FX / Currency Headwinds

ABBOTT LABORATORIES · 2026-07-28 · Importance 43 · Surprise 32 · From source text

Abbott’s cumulative foreign-currency translation loss was $6.26 billion at June 30, 2026, compared with $5.93 billion at December 31, 2025. Foreign-currency translation adjustments produced a $1.55 billion net-of-tax comprehensive-income benefit in the first six months of 2026, indicating a material period-to-period currency effect. Abbott maintained $7.9 billion of notional cash-flow hedges and $13.6 billion of other foreign-currency forward contracts at June 30, 2026, with cash-flow hedge effects expected to flow through cost of products sold over the next 12 to 18 months.

Key facts

• Abbott held foreign currency forward exchange contracts (for intercompany/trade) with gross notional amounts of $13.6 billion at June 30, 2026 and $13.1 billion at December 31, 2025.
• Abbott held foreign currency forward exchange contracts designated as cash flow hedges with gross notional amounts totaling $7.9 billion at June 30, 2026 and $7.4 billion at December 31, 2025.
• Accumulated other comprehensive income (loss) cumulative foreign currency translation adjustments at June 30, 2026: $(6,260) million and at December 31, 2025: $(5,931) million.
• Abbott recognized net foreign currency translation gain adjustments of $1,000 million in the three months ended June 30, 2026 (other comprehensive income components).

Impact estimates